Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
    • PYQ Mastery Program
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
      • PYQ Mastery Program
    • Portal Login

    After 30 years, India began to make Penicillin G

    • March 3, 2024
    • Posted by: OptimizeIAS Team
    • Category: DPN Topics
    No Comments

     

     

    After 30 years, India began to make Penicillin G

    Subject: Science and tech

    Section: Health

    Context:

    The common antibiotic penicillin will be manufactured in the country for the first time in 30  years.

    More on news:

    • Forty greenfield projects under the PLI schemes for manufacturing bulk drugs and medical devices were inaugurated on Saturday.
    • This included 27 greenfield bulk drug projects and 13 manufacturing plants for medical devices.
    • The bulk drug parks will produce active pharma ingredients for commonly used drugs.

    About Penicillin:

    • Penicillin is a medication used to manage and treat a wide range of infections.
    • It is in the beta-lactam antibiotic class of drugs. 
    • This activity describes penicillin’s indications, action, and contraindications as a valuable agent in treating infection.

    About Active Pharmaceutical  Ingredients:

    • These are the active ingredients contained in a medicine.
    • It is that part of the medicine that produces the intended therapeutic effects.
    • For example, in a painkiller, the active ingredient relieves pain.
    • In the OTC drug Crocin, the API is paracetamol.
    • Only a small amount of the API is required to produce the effect and so the medicine contains only the required amount of the API.
    • China is one of the largest producers of Key Starting Material (KSM) and APIs in the world

    About Production Linked Incentive (PLI) Scheme:

    • The scheme expected to give a fillip to the domestic drug manufacturing industry is the PLI Scheme.
    • This scheme aims to promote the domestic manufacturing of, apart from APIs, drug intermediates and key starting materials (KSMs).
    • In this scheme, financial incentives will be provided to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years.
    • The scheme will be implemented through a Project Management Agency (PMA) to be nominated by the Department of Pharmaceuticals.

    Drugs in news:

    • Atorvastatin: Reducing Cholesterol
    • Lopinavir: Treating HIV
    • Acyclovir: Treating infection such as shingles etc.
    India began to make Penicillin G Science and tech
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search